Astellas Pharma gets U.S. nod for blood cancer treatment

Japan's Astellas Pharma Inc on Wednesday received approval from the U.S. Food and Drug Administration for its blood cancer treatment, according to the regulator's website https://bit.ly/2SjB8CL.

from Reuters: Health News https://ift.tt/2E1z13z
via IFTTT